NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+22.5%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.06B
AUM Growth
+$2.06B
(+4.8%)
Cap. Flow
-$189M
Cap. Flow
% of AUM
-9.17%
Top 10 Holdings %
Top 10 Hldgs %
74.94%
Holding
37
New
2
Increased
3
Reduced
5
Closed
2
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$53M |
| 2 |
LOXO
Loxo Oncology, Inc
LOXO
|
$21.1M |
| 3 |
TRVN
Trevena, Inc.
TRVN
|
$5.98M |
| 4 |
Lexicon Pharmaceuticals
LXRX
|
$4.55M |
| 5 |
AGRX
Agile Therapeutics, Inc
AGRX
|
$619K |
Top Sells
| 1 |
Groupon
GRPN
|
$84.1M |
| 2 |
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
|
$73.7M |
| 3 |
CVT
CVENT, INC.
CVT
|
$55.6M |
| 4 |
Nektar Therapeutics
NKTR
|
$22M |
| 5 |
Ardelyx
ARDX
|
$18.9M |
Sector Composition
| 1 | Healthcare | 52.78% |
| 2 | Communication Services | 18.33% |
| 3 | Technology | 12.38% |
| 4 | Consumer Discretionary | 1.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gyre Therapeutics
GYRE
$698M
| $12M | 0.58% |
4,566,666
| – | – |
|
|
VIRX
27
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $11.9M | 0.58% |
4,659,333
| – | – |
|
28
Aurinia Pharmaceuticals
AUPH
$1.55B
| $9.27M | 0.45% |
2,546,843
| – | – |
|
|
DZSI
29
DELISTED
DZS Inc. Common Stock
DZSI
| $8.46M | 0.41% |
4,781,290
| – | – |
|
30
Rigel Pharmaceuticals
RIGL
$702M
| $7.36M | 0.36% |
3,243,150
| – | – |
|
|
PRTK
31
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $6.7M | 0.33% |
173,894
-1,912,861
| -92% | -$73.7M |
|
32
Exelixis
EXEL
$10B
| $3.18M | 0.15% |
2,207,000
| – | – |
|
|
ARQL
33
DELISTED
Arqule Inc
ARQL
| $3.08M | 0.15% |
2,520,316
| – | – |
|
|
AGRX
34
DELISTED
Agile Therapeutics, Inc
AGRX
| $802K | 0.04% |
130,644
+100,794
| +338% | +$619K |
|
|
NURO
35
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $112K | 0.01% |
57,273
| – | – |
|
|
36
Nektar Therapeutics
NKTR
$546M
| – | – |
-1,825,600
| Closed | -$22M |
|
|
ALIM
37
DELISTED
Alimera Sciences, Inc.
ALIM
| – | – |
-2,255,639
| Closed | -$12.2M |
|